Celgosivir

DB06580InvestigationalSmall molecule

Investigated for use/treatment in hepatitis (viral, C).

Chemical structure of Celgosivir
Primary indication
Investigated for use/treatment in hepatitis (viral, C).Curator reviewed
Formula / weight
C12H21NO5 · 259.302 g/mol (avg)
Code names
MDL 28,574

Resolves to

Compound
UNII895VG117HNCAS121104-96-9ChEMBLCHEMBL2110737
Structure
InChIKeyHTJGLYIJVSDQAE-VWNXEWBOSA-NSMILESCCCC(=O)O[C@H]1CN2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O
Targets
O43451MGAM

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Celgosivir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In